memo & hrc

Tel : +44 (0)1382 383119

The FAST study (Febuxostat versus Allopurinol Streamlined Trial)

May we keep in touch with you?

In a recent study newsletter we mentioned that we would like to be able to keep in touch with you once FAST has finished. This would enable us to send you details of the results of the study when they are published and to alert you to any new studies that you might be interested in taking part in.

As an example, we might wish to do a long term follow up of FAST study participants or to see if lowering uric acid might also protect against developing dementia but also possibly other interesting things.

With the recent changes in the Data Protection legislation (GDPR) which came into effect on 25th May 2018 we are also required to ensure that we have your consent to contact you.

If you are happy for us to contact you in the future about the results of the FAST study and other medical research studies we would appreciate you confirming your postal address and providing us with your email address.

We will store the contact details you that you provide on our secure database. These details will be held confidentially in MEMO Research, part of the University of Dundee and will only be viewed by those members of the MEMO Research team at University of Dundee who have been delegated and approved to do so.


Please note you will be redirected to the MEMO Research website to provide contact consent.

Study Results

The results of the FAST Study for patients presented by Prof. Thomas MacDonald

For more information please see our FAST Study Results page.

For more information about what MEMO hopes to achieve, visit, or to read more on some of MEMOs other trials, click on the trial images below...